We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Pediatric Neuroblastoma Treatment Market Size, Insights, Key Players, Business Opportunities, Covid-19 Impact And Emerging Trends By 2028




 

The latest update of “Global Pediatric Neuroblastoma Treatment Market” released by Stratagem Market Insights, forecasts further growth in the global supply and demand. The market report builds upon our previous iteration and the new release reinforces the sentiment that the 2021-2028 period is expected to be a promising period for the global Pediatric Neuroblastoma Treatment Market.

Overview of the Pediatric Neuroblastoma Treatment Market:

Neuroblastoma is a cancerous tumor that begins in the nerve tissue of infants and very young children. The abnormal cells are often found in the nerve tissue, which presents the unborn baby and later develops into a detectable tumor. The global pediatric neuroblastoma treatment market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global pediatric neuroblastoma treatment market is expected to witness significant growth during the forecast period, owing to a rise in awareness about available treatments.

Market Driver

Rising prevalence of neuroblastoma among children is expected to drive growth of the global pediatric neuroblastoma treatment market during the forecast period. Pediatric neuroblastoma has become a major health issue in both developed and emerging economies. According to the American Cancer Society (ACS), neuroblastoma is the most common cancer in infants and accounts for around 6% of all cancers in the U.S. children. According to the same source, there around 800 new cases of neuroblastoma each year in the U.S. Such a high prevalence of neuroblastoma has increased the demand for its treatment. Hence, these factors are drive growth of the global pediatric neuroblastoma treatment market during the forecast period. Furthermore, rise in awareness about available treatments is expected to propel the global pediatric neuroblastoma treatment market growth over the forecast period.

Market Restraint

High research and development costs related to cancer therapy is expected to restrain growth of the global pediatric neuroblastoma treatment market during the forecast period.

Regional Insights

Among regions, North America is expected to witness significant growth in the global pediatric neuroblastoma treatment market during the forecast period. This is owing to rising cases of neuroblastoma among children across the region. Moreover, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to improving healthcare infrastructure across the region.

Competitive Section

Key companies operating in the global pediatric neuroblastoma treatment market are APEIRON Biologics AG, MacroGenics, Inc., United Therapeutics Corporation, Bayer AG, Baxter, Cellectar Biosciences, Inc., and Pfizer, Inc.

Major market players are involved in research and development activities, in order to gain a competitive edge in the market. For instance, in February 2020, Cellectar Biosciences, Inc. announced positive data from its Phase 2 Clover-1 study in patients with relapsed/refractory B-cell lymphomas.

Market Estimation:

The data processed and validated in secondary and primary research is analyzed to compute market estimation statistics. It involves market breakdown, bottom-up, and top-down research. Our research team considers macroeconomic factors to forecast a comprehensive statistical time series. Each data point is validated through the process data triangulation method to derive the final market estimation.

COVID-19 Impact:

The updated report, free extract available, comes with an option to access premium features that covers extensive past, current, and future data. Other valuable updates to the global Pediatric Neuroblastoma Treatment Market report include a reviewed and refined pricing model for manufacturing and launch prices. The report incorporates new content to help give decision-makers key knowledge about the market and offers up-to-date forecasts accounting for the economic situation and impact of COVID-19.

Market Competition Assessment:

The Pediatric Neuroblastoma Treatment Market is observed as the most diversified and competitive market comprising a large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are

  • United Therapeutics Corporation
  • APEIRON Biologics AG
  • Baxter International
  • APAC Biotech
  • Sun Pharmaceutical Industries, Inc.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2028. For the purpose of this study, Stratagem Market Insights has segmented the global Pediatric Neuroblastoma Treatment Market report on the basis of Types, Applications, and Regions.

By Product Type, the market is primarily segmented into:

  • Chemotherpay
  • Immunotherapy
  • Others

By Applications, the market is segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies

The report covers the following Regions:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Africa
  • Middle East

Primary Research Insights:

The process of primary research starts with the verification and validation of every detail obtained in secondary research. This is done with the help of industry experts and in-house analysts who check the authentication of the data. Stratagem Market Insights also ensures that our research is not restricted by certain boundaries, which is why we consult each individual in the value chain including raw materials suppliers, local vendors, wholesale dealers, distributors, etc. We also make sure that every detail provided in the document will hold a certain value and it will not be trivial information. Moreover, current market trends, growth opportunities, drivers, and restraints are computed in primary research only.

The Report Sheds Light on Various Aspects of the Market, Some of the important ones are:

  1. What can be the best investment choices for venturing into new product and service lines?
  2. Which regions might see the demand maturing in certain segments in near future?
  3. Which government regulations might challenge the status of key regional markets?
  4. What are some of the value-grab opportunities in various segments?
  5. What will be the barrier to entry for new players in the market?

Why You Should Buy This Report:

  • The report provides an all-inclusive environment of the analysis for the market
  • In-depth secondary research and primary interviews
  • Impact of various social, political, and economic factors
  • Porter’s Five Forces Analysis
  • Competitive Landscape

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into a specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Content

 

1 Report Overview

 

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatric Neuroblastoma Treatment Market Revenue
1.4 Market Analysis by Type
1.5 Market by Application
1.5.1 Global Pediatric Neuroblastoma Treatment Market Share by Application: 2021 VS 2027
1.6 Coronavirus Disease 2019 (Covid-19) Impact: Pediatric Neuroblastoma Treatment Market
1.6.1 How the Covid-19 is Affecting the Pediatric Neuroblastoma Treatment Market
1.6.1.1 Pediatric Neuroblastoma Treatment Market Business Impact Assessment - Covid-19
1.6.2 Market Trends and Pediatric Neuroblastoma Treatment Market Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

 

2 Global Growth Trends by Regions

 

2.1 Pediatric Neuroblastoma Treatment Market Perspective (2015-2027)
2.2 Pediatric Neuroblastoma Treatment Market Growth Trends by Regions
2.2.1 Pediatric Neuroblastoma Treatment Market Size by Regions: 2015 VS 2021 VS 2027
2.2.2 Pediatric Neuroblastoma Treatment Market Historic Market Share by Regions (2015-2021)
2.2.3 Pediatric Neuroblastoma Treatment Market Forecasted Market Size by Regions (2021-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Pediatric Neuroblastoma Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Pediatric Neuroblastoma Treatment Market Players (Opinion Leaders)

 

3 Competition Landscape by Key Players

 

3.1 Global Top Pediatric Neuroblastoma Treatment Market Players by Market Size
3.1.1 Global Top Pediatric Neuroblastoma Treatment Market Players by Revenue (2015-2021)
3.1.2 Global Pediatric Neuroblastoma Treatment Market Revenue Market Share by Players (2015-2021)
3.1.3 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio
3.2.1 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pediatric Neuroblastoma Treatment Market Revenue in 2019
3.3 Pediatric Neuroblastoma Treatment Market Key Players Head office and Area Served
3.4 Key Players Pediatric Neuroblastoma Treatment Market Product Solution and Service
3.5 Date of entering into Pediatric Neuroblastoma Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

 

4 Breakdown Data by Type (2015-2027)

 

4.1 Global Pediatric Neuroblastoma Treatment Market Historic Market Size by Type (2015-2021)
4.2 Global Pediatric Neuroblastoma Treatment Market Forecasted Market Size by Type (2021-2027)

 

5 Pediatric Neuroblastoma Treatment Market Breakdown Data by Application (2015-2027)

 

5.1 Global Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021)
5.2 Global Pediatric Neuroblastoma Treatment Market Forecasted Market Size by Application (2021-2027)

 

6 North America

 

6.1 North America Pediatric Neuroblastoma Treatment Market Size (2015-2021)
6.2 Pediatric Neuroblastoma Treatment Market Key Players in North America (2019-2021)
6.3 North America Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021)
6.4 North America Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021)

 

7 Europe

 

7.1 Europe Pediatric Neuroblastoma Treatment Market Size (2015-2021)
7.2 Pediatric Neuroblastoma Treatment Market Key Players in Europe (2019-2021)
7.3 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021)
7.4 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021)

 

8 China

 

8.1 China Pediatric Neuroblastoma Treatment Market Size (2015-2021)
8.2 Pediatric Neuroblastoma Treatment Market Key Players in China (2019-2021)
8.3 China Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021)
8.4 China Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021)

 

9 Japan

 

9.1 Japan Pediatric Neuroblastoma Treatment Market Size (2015-2021)
9.2 Pediatric Neuroblastoma Treatment Market Key Players in Japan (2019-2021)
9.3 Japan Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021)
9.4 Japan Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021)

 

10 Southeast Asia

 

10.1 Southeast Asia Pediatric Neuroblastoma Treatment Market Size (2015-2021)
10.2 Pediatric Neuroblastoma Treatment Market Key Players in Southeast Asia (2019-2021)
10.3 Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021)
10.4 Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021)

 

11 India

 

11.1 India Pediatric Neuroblastoma Treatment Market Size (2015-2021)
11.2 Pediatric Neuroblastoma Treatment Market Key Players in India (2019-2021)
11.3 India Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021)
11.4 India Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021)

 

12 Central & South America

 

12.1 Central & South America Pediatric Neuroblastoma Treatment Market Size (2015-2021)
12.2 Pediatric Neuroblastoma Treatment Market Key Players in Central & South America (2019-2021)
12.3 Central & South America Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021)
12.4 Central & South America Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021)

 

13 Key Players Profiles

 

13.1 Company Details
13.2 Business Overview and Its Total Revenue
13.3 Pediatric Neuroblastoma Treatment Market Introduction
13.4 Pediatric Neuroblastoma Treatment Market Business (2015-2021)
13.5 Recent Development

 

14 Analyst's Viewpoints/Conclusions

 

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

 

List of Table

 

Table 1. Pediatric Neuroblastoma Treatment Market Key Market Segments
Table 2. Key Players Covered: Ranking by Pediatric Neuroblastoma Treatment Market Revenue
Table 3. Ranking of Global Top Pediatric Neuroblastoma Treatment Market Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 5. COVID-19 Impact Global Market
Table 6. Opportunities and Trends for Pediatric Neuroblastoma Treatment Market Players in the COVID-19 Landscape
Table 7. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 8. Key Regions/Countries Measures against Covid-19 Impact
Table 9. Proposal for Pediatric Neuroblastoma Treatment Market Players to Combat Covid-19 Impact
Table 10. Global Pediatric Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 11. Global Pediatric Neuroblastoma Treatment Market Size by Regions (US$ Million): 2021 VS 2027
Table 12. Global Pediatric Neuroblastoma Treatment Market Size by Regions (2015-2021) (US$ Million)
Table 13. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2015-2021)
Table 14. Global Pediatric Neuroblastoma Treatment Market Forecasted Market Size by Regions (2021-2027) (US$ Million)
Table 15. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2021-2027)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Pediatric Neuroblastoma Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Pediatric Neuroblastoma Treatment Market Players
Table 21. Global Pediatric Neuroblastoma Treatment Market Revenue by Players (2015-2021) (Million US$)
Table 22. Global Pediatric Neuroblastoma Treatment Market Share by Players (2015-2021)
Table 23. Global Top Pediatric Neuroblastoma Treatment Market Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Neuroblastoma Treatment Market as of 2019)
Table 24. Global Pediatric Neuroblastoma Treatment Market by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Pediatric Neuroblastoma Treatment Market Product Solution and Service
Table 27. Date of entering into Pediatric Neuroblastoma Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021) (Million US$)
Table 30. Global Pediatric Neuroblastoma Treatment Market Size Share by Type (2015-2021)
Table 31. Global Pediatric Neuroblastoma Treatment Market Revenue Market Share by Type (2021-2027)
Table 31. Global Pediatric Neuroblastoma Treatment Market Size Share by Application (2015-2021)
Table 33. Global Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021) (Million US$)
Table 34. Global Pediatric Neuroblastoma Treatment Market Size Share by Application (2021-2027)
Table 35. North America Key Players Pediatric Neuroblastoma Treatment Market Revenue (2019-2021) (Million US$)
Table 36. North America Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2021)
Table 37. North America Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021) (Million US$)
Table 38. North America Pediatric Neuroblastoma Treatment Market Share by Type (2015-2021)
Table 39. North America Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021) (Million US$)
Table 40. North America Pediatric Neuroblastoma Treatment Market Share by Application (2015-2021)
Table 41. Europe Key Players Pediatric Neuroblastoma Treatment Market Revenue (2019-2021) (Million US$)
Table 42. Europe Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2021)
Table 43. Europe Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021) (Million US$)
Table 44. Europe Pediatric Neuroblastoma Treatment Market Share by Type (2015-2021)
Table 45. Europe Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021) (Million US$)
Table 46. Europe Pediatric Neuroblastoma Treatment Market Share by Application (2015-2021)
Table 47. China Key Players Pediatric Neuroblastoma Treatment Market Revenue (2019-2021) (Million US$)
Table 48. China Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2021)
Table 49. China Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021) (Million US$)
Table 50. China Pediatric Neuroblastoma Treatment Market Share by Type (2015-2021)
Table 51. China Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021) (Million US$)
Table 52. China Pediatric Neuroblastoma Treatment Market Share by Application (2015-2021)
Table 53. Japan Key Players Pediatric Neuroblastoma Treatment Market Revenue (2019-2021) (Million US$)
Table 54. Japan Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2021)
Table 55. Japan Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021) (Million US$)
Table 56. Japan Pediatric Neuroblastoma Treatment Market Share by Type (2015-2021)
Table 57. Japan Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021) (Million US$)
Table 58. Japan Pediatric Neuroblastoma Treatment Market Share by Application (2015-2021)
Table 59. Southeast Asia Key Players Pediatric Neuroblastoma Treatment Market Revenue (2019-2021) (Million US$)
Table 60. Southeast Asia Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2021)
Table 61. Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021) (Million US$)
Table 62. Southeast Asia Pediatric Neuroblastoma Treatment Market Share by Type (2015-2021)
Table 63. Southeast Asia Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021) (Million US$)
Table 64. Southeast Asia Pediatric Neuroblastoma Treatment Market Share by Application (2015-2021)
Table 65. India Key Players Pediatric Neuroblastoma Treatment Market Revenue (2019-2021) (Million US$)
Table 66. India Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2021)
Table 67. India Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021) (Million US$)
Table 68. India Pediatric Neuroblastoma Treatment Market Share by Type (2015-2021)
Table 69. India Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021) (Million US$)
Table 70. India Pediatric Neuroblastoma Treatment Market Share by Application (2015-2021)
Table 71. Central & South America Key Players Pediatric Neuroblastoma Treatment Market Revenue (2019-2021) (Million US$)
Table 72. Central & South America Key Players Pediatric Neuroblastoma Treatment Market Share (2019-2021)
Table 73. Central & South America Pediatric Neuroblastoma Treatment Market Size by Type (2015-2021) (Million US$)
Table 74. Central & South America Pediatric Neuroblastoma Treatment Market Share by Type (2015-2021)
Table 75. Central & South America Pediatric Neuroblastoma Treatment Market Size by Application (2015-2021) (Million US$)
Table 76. Central & South America Pediatric Neuroblastoma Treatment Market Share by Application (2015-2021)
Table 77. Company Details
Table 78. Business Overview
Table 79. Product details
Table 80. Revenue in Pediatric Neuroblastoma Treatment Market Business (2015-2021) (Million US$)
Table 81. Recent Development

 

List of Figures

 

Figure 1. Global Pediatric Neuroblastoma Treatment Market Share by Type: 2021 VS 2027
Figure 2. Global Pediatric Neuroblastoma Treatment Market Share by Application: 2021 VS 2027
Figure 3. Emergency Care Case Studies
Figure 4. Outpatient Facilities Case Studies
Figure 5. Hospitals Case Studies
Figure 6. Home Healthcare Facilities Case Studies
Figure 7. Pediatric Neuroblastoma Treatment Market Report Years Considered
Figure 8. Global Pediatric Neuroblastoma Treatment Market Size YoY Growth 2015-2027 (US$ Million)
Figure 9. Global Pediatric Neuroblastoma Treatment Market Share by Regions: 2021 VS 2027
Figure 10. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2021-2027)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Pediatric Neuroblastoma Treatment Market Share by Players in 2019
Figure 13. Global Top Pediatric Neuroblastoma Treatment Market Players by Company Type (Tier 1, Tier 2, and Tier 3) (based on the Revenue in Pediatric Neuroblastoma Treatment Market as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Market Revenue in 2019
Figure 15. North America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 16. Europe Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 17. China Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 18. Japan Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 19. Southeast Asia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 20. India Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 21. Central & South America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2015-2021) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.